Intra-amygdala microinjection of TNF-α impairs the auditory fear conditioning of rats via glutamate toxicity

Neuroscience Research

Volumn 91, Issue , 2015, Pages 34-40

  Jing, He ^a   Hao, Yongxin ^a   Bi, Qiang ^a   Zhang, Jiaozhen ^a   Yang, Pingting ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Amygdala; Fear conditioning; Glutamate; NMDAR; TNF

Indexed keywords

4 AMINOBUTYRIC ACID; DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDITORY SYSTEM; AVOIDANCE BEHAVIOR; BEHAVIOR CHANGE; COGNITION; CONDITIONING; CONTROLLED STUDY; DRUG INFUSION; EXCITOTOXICITY; FEAR; FEAR LEARNING; LEARNING; LEARNING DISORDER; MALE; MEMORY; MEMORY DISORDER; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; ANIMAL; ANTAGONISTS AND INHIBITORS; AUDITORY STIMULATION; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ACOUSTIC STIMULATION; AMYGDALA; ANIMALS; CONDITIONING (PSYCHOLOGY); FEAR; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; LEARNING; MALE; MEMORY; MICROINJECTIONS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923924861     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2014.10.015     Document Type: Article

References (42)

1. Aloe L., Properzi F., Probert L., Akassoglou K., Kassiotis G., Micera A., Fiore M. Learning abilities, NGF and BDNF brain levels in two lines of TNF-alpha transgenic mice, one characterized by neurological disorders, the other phenotypically normal. Brain Res. 1999, 840:125-137.
2. Baker J.D., Azorlosa J.L. The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning. Behav. Neurosci. 1996, 110:618-620.
3. Benveniste H. Glutamate, microdialysis, and cerebral ischemia: lost in translation?. Anesthesiology 2009, 110:422-425.
4. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 2001, 4:702-710.
5. Blanchard R.J., Blanchard D.C. Passive and active reactions to fear-eliciting stimuli. J. Comp. Physiol. Psychol. 1969, 68:129-135.
6. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
7. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y., Hirsch E.C. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 1994, 172:151-154.
8. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7162-7166.
9. Breder C.D., Tsujimoto M., Terano Y., Scott D.W., Saper C.B. Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. J. Comp. Neurol. 1993, 337:543-567.
10. Brennan F.X., Beck K.D., Servatius R.J. Proinflammatory cytokines differentially affect leverpress avoidance acquisition in rats. Behav. Brain Res. 2004, 153:351-355.
11. Butler M.P., O'Connor J.J., Moynagh P.N. Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience 2004, 124:319-326.
12. Churchill L., Rector D.M., Yasuda K., Fix C., Rojas M.J., Yasuda T., Krueger J.M. Tumor necrosis factor alpha: activity dependent expression and promotion of cortical column sleep in rats. Neuroscience 2008, 156:71-80.
13. Cunningham A.J., Murray C.A., O'Neill L.A., Lynch M.A., O'Connor J.J. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 1996, 203:17-20.
14. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
15. Ferguson A.R., Christensen R.N., Gensel J.C., Miller B.A., Sun F., Beattie E.C., Bresnahan J.C., Beattie M.S. Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J. Neurosci. 2008, 28:11391-11400.
16. Gelbard H., Dzenko K., DiLoreto D., del Cerro C., del Cerro M., Epstein L. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev. Neurosci. 1993, 15:417-422.
17. Golan H., Levav T., Mendelsohn A., Huleihel M. Involvement of tumor necrosis factor alpha in hippocampal development and function. Cereb. Cortex 2004, 14:97-105.
18. Kim J.J., Jung M.W. Neural circuits and mechanisms involved in Pavlovian fear conditioning: a critical review. Neurosci. Biobehav. Rev. 2006, 30:188-202.
19. Komuro H., Rakic P. Intracellular Ca2+ fluctuations modulate the rate of neuronal migration. Neuron 1996, 17:275-285.
20. Langton J.M., Kim J.H., Nicholas J., Richardson R. The effect of the NMDA receptor antagonist MK-801 on the acquisition and extinction of learned fear in the developing rat. Learn. Mem. 2007, 14:665-668.
21. Leist M., Nicotera P. Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 1998, 239:183-201.
22. Lipton S.A. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Dev. Neurosci. 1994, 16:145-151.
23. Liu J.-L., Li M., Dang X.-R., Wang Z.-H., Rao Z.-R., Wu S.-X., Li Y.-Q., Wang W. A NMDA receptor antagonist, MK-801 impairs consolidating extinction of auditory conditioned fear responses in a Pavlovian model. PLoS ONE 2009, 4:e7548.
24. LoTurco J.J., Blanton M.G., Kriegstein A.R. Initial expression and endogenous activation of NMDA channels in early neocortical development. J. Neurosci. 1991, 11:792-799.
25. Maren S. Neurobiology of Pavlovian fear conditioning. Annu. Rev. Neurosci. 2001, 24:897-931.
26. Martin S.J., Grimwood P.D., Morris R.G. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 2000, 23:649-711.
27. McEntee W.J., Crook T.H. Glutamate: its role in learning, memory, and the aging brain. Psychopharmacology (Berl.) 1993, 111:391-401.
28. Montgomery S.L., Bowers W.J. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. J. Neuroimmune Pharmacol. 2012, 7:42-59.
29. Nokta M.A., Hassan M.I., Loesch K.A., Pollard R.B. HIV-induced TNF-alpha regulates arachidonic acid and PGE2 release from HIV-infected mononuclear phagocytes. Virology 1995, 208:590-600.
30. Paré D. Mechanisms of Pavlovian fear conditioning: has the engram been located?. Trends Neurosci. 2002, 25:436-437. discussion 437-8.
31. Paré D., Quirk G.J., Ledoux J.E. New vistas on amygdala networks in conditioned fear. J. Neurophysiol. 2004, 92:1-9.
32. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, New York.
33. Perry V.H., Newman T.A., Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 2003, 4:103-112.
34. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmächer T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 2001.
35. Santello M., Bezzi P., Volterra A. TNFα controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron 2011, 69:988-1001.
36. Sriram K., O'Callaghan J.P. Divergent roles for tumor necrosis factor-alpha in the brain. J. Neuroimmune Pharmacol. 2007, 2:140-153.
37. Stellwagen D., Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 2006, 440:1054-1059.
38. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T., Suzumura A. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 2006, 281:21362-21368.
39. Tancredi V., D'Arcangelo G., Grassi F., Tarroni P., Palmieri G., Santoni A., Eusebi F. Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci. Lett. 1992, 146:176-178.
40. Tchelingerian J.L., Quinonero J., Booss J., Jacque C. Localization of TNF alpha and IL-1 alpha immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron 1993, 10:213-224.
41. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain. Behav. Immun. 2011, 25:181-213.
42. Zhao J., Lopez A.L., Erichsen D., Herek S., Cotter R.L., Curthoys N.P., Zheng J. Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: linkage to HIV-1 associated dementia. J. Neurochem. 2004, 88:169-180.